This came after Takeda Biopharmaceuticals presented the proposal for an update in the package insert regarding home infusion ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Nammi Therapeutics, Inc. (Nammi), a clinical stage immuno-oncology company with a diverse pipeline created with the Masked-Immunocytokine (MIC) and Nammisome platforms, announces dosing of the first ...

Good afternoon, everyone. Thank you for standing by. Welcome to CytomX Therapeutics third quarter, 2024 Financial results call. Please be advised that today's call is being recorded. I would now like ...

Researchers explore the mechanisms, therapeutic potential, and clinical applications of curcumin in preventing and treating ...

Through scientific analysis of geospatial information and patented sensors and processing technology, the Company provisions diverse, complementary, multi-source datasets ... at 12:52 Plato Systems ...

Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for ...

If you have seen the movie Inside Out, you might already be familiar with the concept of internal family systems, or IFS, therapy. Developed by Dr. Richard Schwartz in the 1980s, IFS is a model of ...

Researchers found that the enzymes or proteins with significant response to overactive antibodies were a class of enzymes known as endo-ß-N-acetyglucosaminidases (ENGases). These particular enzymes ...